Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor

Hirohide Matsuura, Toshihiro Ichiki, Jiro Ikeda, Kotaro Takeda, Ryohei Miyazaki, Toru Hashimoto, Eriko Narabayashi, Shiro Kitamoto, Tomotake Tokunou, Kenji Sunagawa

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Inhibition of prolyl hydroxylase domain-containing protein (PHD) by hypoxia stabilizes hypoxia-inducible factor 1 and increases the expression of target genes, such as vascular endothelial growth factor. Although the systemic renin-angiotensin system is activated by hypoxia, the role of PHD in the regulation of the renin-angiotensin system remains unknown. We examined the effect of PHD inhibition on the expression of angiotensin II type 1 receptor (AT1R). Hypoxia, cobalt chloride, and dimethyloxalylglycine, all known to inhibit PHD, reduced AT1R expression in vascular smooth muscle cells. Knockdown of PHD2, a major isoform of PHDs, by RNA interference also reduced AT1R expression. Cobalt chloride diminished angiotensin II-induced extracellular signal-regulated kinase phosphorylation. Cobalt chloride decreased AT1R mRNA through transcriptional and posttranscriptional mechanisms. Oral administration of cobalt chloride (14 mg/kg per day) to C57BL/6J mice receiving angiotensin II infusion (490 ng/kg per minute) for 4 weeks significantly attenuated perivascular fibrosis of the coronary arteries without affecting blood pressure level. These data suggest that PHD inhibition may be beneficial for the treatment of cardiovascular diseases by inhibiting renin-angiotensin system via AT1R downregulation.

Original languageEnglish
Pages (from-to)386-393
Number of pages8
JournalHypertension
Volume58
Issue number3
DOIs
Publication statusPublished - Sep 1 2011

Fingerprint

Prolyl Hydroxylases
Angiotensin Type 1 Receptor
Blood Vessels
Down-Regulation
Renin-Angiotensin System
Angiotensin II
Hypoxia-Inducible Factor 1
Extracellular Signal-Regulated MAP Kinases
RNA Interference
Inbred C57BL Mouse
Vascular Smooth Muscle
Vascular Endothelial Growth Factor A
Smooth Muscle Myocytes
Oral Administration
Coronary Vessels
Protein Isoforms
Fibrosis
Cardiovascular Diseases
Phosphorylation
Protein Domains

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor. / Matsuura, Hirohide; Ichiki, Toshihiro; Ikeda, Jiro; Takeda, Kotaro; Miyazaki, Ryohei; Hashimoto, Toru; Narabayashi, Eriko; Kitamoto, Shiro; Tokunou, Tomotake; Sunagawa, Kenji.

In: Hypertension, Vol. 58, No. 3, 01.09.2011, p. 386-393.

Research output: Contribution to journalArticle

Matsuura, H, Ichiki, T, Ikeda, J, Takeda, K, Miyazaki, R, Hashimoto, T, Narabayashi, E, Kitamoto, S, Tokunou, T & Sunagawa, K 2011, 'Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor', Hypertension, vol. 58, no. 3, pp. 386-393. https://doi.org/10.1161/HYPERTENSIONAHA.110.167106
Matsuura, Hirohide ; Ichiki, Toshihiro ; Ikeda, Jiro ; Takeda, Kotaro ; Miyazaki, Ryohei ; Hashimoto, Toru ; Narabayashi, Eriko ; Kitamoto, Shiro ; Tokunou, Tomotake ; Sunagawa, Kenji. / Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor. In: Hypertension. 2011 ; Vol. 58, No. 3. pp. 386-393.
@article{2d989725898d48de930bd5cd784ebf21,
title = "Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor",
abstract = "Inhibition of prolyl hydroxylase domain-containing protein (PHD) by hypoxia stabilizes hypoxia-inducible factor 1 and increases the expression of target genes, such as vascular endothelial growth factor. Although the systemic renin-angiotensin system is activated by hypoxia, the role of PHD in the regulation of the renin-angiotensin system remains unknown. We examined the effect of PHD inhibition on the expression of angiotensin II type 1 receptor (AT1R). Hypoxia, cobalt chloride, and dimethyloxalylglycine, all known to inhibit PHD, reduced AT1R expression in vascular smooth muscle cells. Knockdown of PHD2, a major isoform of PHDs, by RNA interference also reduced AT1R expression. Cobalt chloride diminished angiotensin II-induced extracellular signal-regulated kinase phosphorylation. Cobalt chloride decreased AT1R mRNA through transcriptional and posttranscriptional mechanisms. Oral administration of cobalt chloride (14 mg/kg per day) to C57BL/6J mice receiving angiotensin II infusion (490 ng/kg per minute) for 4 weeks significantly attenuated perivascular fibrosis of the coronary arteries without affecting blood pressure level. These data suggest that PHD inhibition may be beneficial for the treatment of cardiovascular diseases by inhibiting renin-angiotensin system via AT1R downregulation.",
author = "Hirohide Matsuura and Toshihiro Ichiki and Jiro Ikeda and Kotaro Takeda and Ryohei Miyazaki and Toru Hashimoto and Eriko Narabayashi and Shiro Kitamoto and Tomotake Tokunou and Kenji Sunagawa",
year = "2011",
month = "9",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.110.167106",
language = "English",
volume = "58",
pages = "386--393",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor

AU - Matsuura, Hirohide

AU - Ichiki, Toshihiro

AU - Ikeda, Jiro

AU - Takeda, Kotaro

AU - Miyazaki, Ryohei

AU - Hashimoto, Toru

AU - Narabayashi, Eriko

AU - Kitamoto, Shiro

AU - Tokunou, Tomotake

AU - Sunagawa, Kenji

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Inhibition of prolyl hydroxylase domain-containing protein (PHD) by hypoxia stabilizes hypoxia-inducible factor 1 and increases the expression of target genes, such as vascular endothelial growth factor. Although the systemic renin-angiotensin system is activated by hypoxia, the role of PHD in the regulation of the renin-angiotensin system remains unknown. We examined the effect of PHD inhibition on the expression of angiotensin II type 1 receptor (AT1R). Hypoxia, cobalt chloride, and dimethyloxalylglycine, all known to inhibit PHD, reduced AT1R expression in vascular smooth muscle cells. Knockdown of PHD2, a major isoform of PHDs, by RNA interference also reduced AT1R expression. Cobalt chloride diminished angiotensin II-induced extracellular signal-regulated kinase phosphorylation. Cobalt chloride decreased AT1R mRNA through transcriptional and posttranscriptional mechanisms. Oral administration of cobalt chloride (14 mg/kg per day) to C57BL/6J mice receiving angiotensin II infusion (490 ng/kg per minute) for 4 weeks significantly attenuated perivascular fibrosis of the coronary arteries without affecting blood pressure level. These data suggest that PHD inhibition may be beneficial for the treatment of cardiovascular diseases by inhibiting renin-angiotensin system via AT1R downregulation.

AB - Inhibition of prolyl hydroxylase domain-containing protein (PHD) by hypoxia stabilizes hypoxia-inducible factor 1 and increases the expression of target genes, such as vascular endothelial growth factor. Although the systemic renin-angiotensin system is activated by hypoxia, the role of PHD in the regulation of the renin-angiotensin system remains unknown. We examined the effect of PHD inhibition on the expression of angiotensin II type 1 receptor (AT1R). Hypoxia, cobalt chloride, and dimethyloxalylglycine, all known to inhibit PHD, reduced AT1R expression in vascular smooth muscle cells. Knockdown of PHD2, a major isoform of PHDs, by RNA interference also reduced AT1R expression. Cobalt chloride diminished angiotensin II-induced extracellular signal-regulated kinase phosphorylation. Cobalt chloride decreased AT1R mRNA through transcriptional and posttranscriptional mechanisms. Oral administration of cobalt chloride (14 mg/kg per day) to C57BL/6J mice receiving angiotensin II infusion (490 ng/kg per minute) for 4 weeks significantly attenuated perivascular fibrosis of the coronary arteries without affecting blood pressure level. These data suggest that PHD inhibition may be beneficial for the treatment of cardiovascular diseases by inhibiting renin-angiotensin system via AT1R downregulation.

UR - http://www.scopus.com/inward/record.url?scp=80051928109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051928109&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.110.167106

DO - 10.1161/HYPERTENSIONAHA.110.167106

M3 - Article

C2 - 21825224

AN - SCOPUS:80051928109

VL - 58

SP - 386

EP - 393

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -